Company: LHI
Filing Date: 2025-11-20
Form Type: F-1/A
Source: 0001213900-25-112807
Chunk: 23

Company: Living Homeopathy International Ltd.
Filing Date: 2025-11-20
Form: F-1/A
Chunk 23
---
 the criteria as set forth in Article 15
of the Overseas Listing Trial Measures, and are not required to fulfill the filing procedures with the CSRC to list our securities on
a U.S. securities exchange or issue securities to foreign investors. However, as the Overseas Listing Trial Measures were newly published,
there are substantial uncertainties that the CSRC may take a view that is contrary to our understanding of the Overseas Listing Trial
Measures because the CSRC may have substantial discretions over the determination of “indirect overseas offering and listing by
a domestic company”.

Han Kun Law Offices LLP, our Hong Kong counsel, has advised us that, as of the date of this prospectus, Living Homeopathy is not required to obtain any permission or approval from the governmental authorities of Hong Kong to list on the U.S. exchanges and offer securities.

However, if we (i) do not receive or maintain
such permissions or approvals, should such permissions or approvals be required in the future by the PRC or Hong Kong government, (ii)
inadvertently conclude that such permissions or approvals are not required, or (iii) applicable laws, regulations, or interpretations
change and we are required to obtain such permissions or approvals in the future, we may be unable to obtain such permissions or approvals
in a timely manner, or at all, and may face regulatory actions or other sanctions from the CSRC, the CAC or other PRC or Hong Kong regulatory
authorities if we fail to fully comply with any new regulatory requirements. Consequently, our operations and financial conditions could
be materially adversely affected, and our ability to offer securities to investors could be significantly limited or completely hindered
and the securities currently being offered may substantially decline in value and become worthless.

Furthermore, the PRC government may exert more
control over offerings conducted overseas and/or foreign investment in issuers like us. Such governmental actions, if and when occur:
(i) could significantly limit or completely hinder our ability to continue our operations; (ii) could significantly limit or completely
hinder our ability to offer or continue to offer our securities to investors; and (iii) may cause the value of such securities to significantly
decline or be worthless.

Dividend Distributions or Assets Transfer among the Holding Company and Its Subsidiaries

Living Homeopathy’s board of directors has complete discretion as to whether to distribute dividends, subject to certain requirements of Cayman Islands law. In addition, Living Homeopathy’s shareholders may by ordinary resolution declare a dividend, but